Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134


Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.

Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, Valantin MA, Jacomet C, Joly V, Chéret A, Pugliese P, Delobel P, Cabié A, Rey D; Dat’AIDS Study Group.

PLoS One. 2019 Apr 18;14(4):e0215464. doi: 10.1371/journal.pone.0215464. eCollection 2019.


Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort.

Lions C, Cabras O, Cotte L, Huleux T, Gagneux-Brugnon A, Makinson A, Cabié A, Bonnet B, Duvivier C, Hocqueloux L, Cua E, Cheret A, Hustache-Mathieu L, Obry-Roguet V, Jacomet C, Poizot-Martin I; DAT’AIDS STUDY GROUP.

BMC Infect Dis. 2019 Mar 25;19(1):278. doi: 10.1186/s12879-019-3915-5.


HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohort.

Hentzien M, Dramé M, Delpierre C, Allavena C, Cabié A, Cuzin L, Rey D, Pugliese P, Hédelin G, Bani-Sadr F; Dat’AIDS Study Group.

BMJ Open. 2019 Jan 25;9(1):e024841. doi: 10.1136/bmjopen-2018-024841.


Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status.

Baldé A, Lang S, Wagner A, Ferrières J, Montaye M, Tattevin P, Cotte L, Aslangul E, Bidégain F, Chéret A, Mary-Krause M, Meynard JL, Molina JM, Partisani M, Roger PM, Boccara F, Costagliola D.

PLoS One. 2019 Jan 16;14(1):e0210253. doi: 10.1371/journal.pone.0210253. eCollection 2019.


Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial.

Chaix ML, Charreau I, Pintado C, Delaugerre C, Mahjoub N, Cotte L, Capitant C, Raffi F, Cua E, Pialoux G, Tremblay C, Meyer L, Molina JM; ANRS IPERGAY Study Group .

Open Forum Infect Dis. 2018 Nov 8;5(11):ofy295. doi: 10.1093/ofid/ofy295. eCollection 2018 Nov.


Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.

Shaiykova A, Pasquet A, Goujard C, Lion G, Durand E, Bayan T, Lachâtre M, Choisy P, Ajana F, Bourdic K, Viget N, Riff B, Quertainmont Y, Cortet B, Boufassa F, Chéret A.

AIDS. 2018 Nov 28;32(18):2689-2696. doi: 10.1097/QAD.0000000000002001.


Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens.

Potard V, Goujard C, Valantin MA, Lacombe JM, Lahoulou R, Chéret A, Girard PM, Costagliola D; French Hospital Database on HIV (FHDH - ANRS CO4).

BMC Infect Dis. 2018 Jul 11;18(1):326. doi: 10.1186/s12879-018-3231-5.


Motivational interviewing training for medical students: A pilot pre-post feasibility study.

Chéret A, Durier C, Noël N, Bourdic K, Legrand C, D'Andréa C, Hem E, Goujard C, Berthiaume P, Consoli SM.

Patient Educ Couns. 2018 Nov;101(11):1934-1941. doi: 10.1016/j.pec.2018.06.011. Epub 2018 Jun 21.


Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.

Provoost A, Dramé M, Cotte L, Cuzin L, Garraffo R, Rey D, Raffi F, Poizot-Martin I, Pugliese P, Bani-Sadr F; Dat'AIDS study group.

Aliment Pharmacol Ther. 2018 Aug;48(3):281-289. doi: 10.1111/apt.14812. Epub 2018 Jun 14.


Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.

Hentzien M, Cabie A, Pugliese P, Billaud É, Poizot-Martin I, Duvivier C, Valantin MA, Kaladjian A, Dramé M, Bani-Sadr F; Dat'AIDS Study Group.

HIV Med. 2018 Jun 1. doi: 10.1111/hiv.12633. [Epub ahead of print]


Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.

Stefic K, Novelli S, Mahjoub N, Seng R, Molina JM, Cheneau C, Barin F, Chaix ML, Meyer L, Delaugerre C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group .

J Infect Dis. 2018 May 5;217(11):1793-1797. doi: 10.1093/infdis/jiy120.


Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV.

Pradat P, Huleux T, Raffi F, Delobel P, Valantin MA, Poizot-Martin I, Pugliese P, Reynes J, Rey D, Hoen B, Cabie A, Bani-Sadr F, Cheret A, Duvivier C, Jacomet C, Fresard A, Hustache-Mathieu L, Cotte L; Dat’AIDS study Group.

AIDS. 2018 May 15;32(8):1077-1082. doi: 10.1097/QAD.0000000000001789.


Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial.

Pressiat C, Hirt D, Treluyer JM, Zheng Y, Morlat P, Naqvi A, Tran L, Viard JP, Avettand-Fenoel V, Rouzioux C, Meyer L, Cheret A; OPTIPRIM Study Group.

J Antimicrob Chemother. 2018 Apr 1;73(4):1020-1024. doi: 10.1093/jac/dkx498.


Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.

Mercié P, Arsandaux J, Katlama C, Ferret S, Beuscart A, Spadone C, Duvivier C, Reynes J, Wirth N, Moinot L, Bénard A, Zucman D, Duval X, Molina JM, Spire B, Fagard C, Chêne G; ANRS 144 Inter-ACTIV study group.

Lancet HIV. 2018 Mar;5(3):e126-e135. doi: 10.1016/S2352-3018(18)30002-X. Epub 2018 Jan 9.


Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.

Virlogeux V, Zoulim F, Pugliese P, Poizot-Martin I, Valantin MA, Cuzin L, Reynes J, Billaud E, Huleux T, Bani-Sadr F, Rey D, Frésard A, Jacomet C, Duvivier C, Cheret A, Hustache-Mathieu L, Hoen B, Cabié A, Cotte L; Dat’AIDS Study Group.

BMC Med. 2017 Dec 18;15(1):217. doi: 10.1186/s12916-017-0979-1.


Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.

Raymond S, Nicot F, Pallier C, Bellecave P, Maillard A, Trabaud MA, Morand-Joubert L, Rodallec A, Amiel C, Mourez T, Bocket L, Beby-Defaux A, Bouvier-Alias M, Lambert-Niclot S, Charpentier C, Malve B, Mirand A, Dina J, Le Guillou-Guillemette H, Marque-Juillet S, Signori-Schmuck A, Barin F, Si-Mohamed A, Avettand Fenoel V, Roussel C, Calvez V, Saune K, Marcelin AG, Rodriguez C, Descamps D, Izopet J; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group .

Clin Infect Dis. 2018 May 2;66(10):1588-1594. doi: 10.1093/cid/cix1070.


Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.

Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, Capitant C, Rojas-Castro D, Fonsart J, Bercot B, Bébéar C, Cotte L, Robineau O, Raffi F, Charbonneau P, Aslan A, Chas J, Niedbalski L, Spire B, Sagaon-Teyssier L, Carette D, Mestre SL, Doré V, Meyer L; ANRS IPERGAY Study Group.

Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8.


Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).

Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM; ANRS HC31 SOFTRIH Study Group.

HIV Med. 2018 Mar;19(3):227-237. doi: 10.1111/hiv.12571. Epub 2017 Dec 7.


HIV is associated with airway obstruction: a matched controlled study.

Makinson A, Hayot M, Eymard-Duvernay S, Ribet C, Raffi F, Pialoux G, Zucman D, Poizot-Martin I, Bonnet F, Abgrall S, Tattevin P, Cheret A, Ferry T, Mauboussin JM, Marchand L, Rouzaud C, Reynes J, Zins M, Le Moing V; ANRS EP48 HIV CHEST study Team.

AIDS. 2018 Jan 14;32(2):227-232. doi: 10.1097/QAD.0000000000001691.


Diagnosis and treatment of HIV primary infection: the earlier, the better !

Rouzioux C, Avettand-Fénoël V, Cheret A.

Rev Prat. 2017 Oct;67(8):892-895. French.


Supplemental Content

Loading ...
Support Center